Evidence of microevolution in a clinical case of recurrent cryptococcus neoformans meningoencephalitis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 20, Issue 8, 2001, Pages 535-543

  Blasi, E ^a   Brozzetti, A ^b   Francisci, D ^b   Neglia, R ^a   Cardinali, G ^b   Bistoni, F ^b   Vidotto, V ^c   Baldelli, F ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; FUNGAL ENZYME; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; ITRACONAZOLE; PHOSPHOLIPASE; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIFUNGAL ACTIVITY; ARTICLE; BLOOD SAMPLING; CASE REPORT; CELL KILLING; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DRUG SENSITIVITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MALE; MENINGOENCEPHALITIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; MONOCYTE; NORMAL HUMAN; PHAGOCYTOSIS; PHENOTYPE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; RECURRENT INFECTION; RELAPSE; STRAIN DIFFERENCE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL TYPING TECHNIQUES; CEREBROSPINAL FLUID; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; HUMANS; MALE; MENINGOENCEPHALITIS; PHAGOCYTOSIS; PHENOTYPE; RECURRENCE;

EID: 0034808428     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960100549     Document Type: Article

References (54)

1. Cryptococcosis: Population-based multistate active surveillance and risk factor in human immunodeficiency virus-infected persons
2. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis
3. Impaired neutrophil function in patients with AIDS or AIDS related complex: A comprehensive evaluation
4. Cryptococcosis in the era of AIDS - 100 Years after the discovery of Cryptococcus neoformans
5. Recovery of the immune system with antiretroviral therapy. The end of opportunism?
6. Early mycological treatment failure in AIDS-associated cryptococcal meningitis
7. Prospects for the prevention of cryptococcosis in persons infected with human immunodeficiency virus
8. Therapy for cryptococcal meningitis in patients with AIDS
9. Molecular typing of Cryptococcus neoformans: Taxonomic and epidemiological aspects
10. Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification and polymorphic DNA and DNA finger-printing
11. Epidemiological evidence for dormant C. neoformans infection
12. Prostatic sequestration of Cryptococcus neoformans in immunocompromised person treated for cryptococcal meningoencephalitis
13. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole
14. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes
15. Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage
16. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure
17. Improvement of chromosomal DNA extraction from different yeast species by analysis of single preparation steps
18. Non-radioactive dot-blot DNA reassociation for unequivocal yeast identification
19. Application of polymerase chain reaction to fingerprinting Aspergillus fumigatus by random amplification of polymorphic DNA
20. Plate method for detection of phospholipase activity in Candida albicans
21. Extracellular proteolytic activity of Cryptococcus neoformans
22. Karyotyping of Cryptococcus neoformans as an epidemiological tool
23. Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans
24. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis
25. Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients
26. Karyotype instability in Cryptococcus neoformans infection
27. Serial isolates ofCryptococcus neoformans from patient with AIDS differ in virulence for mice
28. Proinflammatory cytokines and immunity
29. Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma-interferon, tumor necrosis factor, and IL-1
30. Cytokine enhancement of complement-dependent phagocytosis by macrophages: Synergy of tumor necrosis factor-α and granulocyte-macrophages colony stimulating factor for phagocytosis of Cryptococcus neoformans
31. Modulation of anti-candida activity of human alveolar macrophages by interferon-gamma and interleukin-1 alpha
32. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions
33. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens
34. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB
35. Immunosuppressive and anti-inflammatory properties of interleukin 10
36. Modulation of macrophage functions by transforming growth factorβ, interleukin-4, and interleukin-10
37. Interleukin-10 (IL-10) inhibits cytokines synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
38. IL-10 induces mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory functions
39. Effector functions of activated macrophages against parasites
40. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells
41. Cytokine treatment of central nervous system infections: Efficacy of interleukin-12 alone and in synergy with conventional antifungaltherapy in experimental cryptococcosis
42. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans
43. Interleukin-12 in infectious diseases
44. Interleukin-12 and its role in the generation of Th1 cells
45. Function and clinical use ofinterleukin-12
46. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis
47. Extracellular proteinase activity of Cryptococcus neoformans
48. Potential role of phospholipase in virulence and fungal pathogenesis
49. Phospholipase activity in Cryptococcus neoformans: A new virulence factor?
50. Phospholipase production in Cryptococcus neoformans isolates from AIDS patients in Thailand and Italy
51. Comparison of phospholipase production in Cryptococcus neoformans isolates from AIDS patients and bird droppings
52. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans
53. Multilocus genotypes and DNA fingerprints do not predict variation in azole resistance among clinical isolates of Candida albicans